Tekla Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Tekla Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-323,883	Closed	-$15M	–	210
2019 Q2	$15M	Sell	323,883 -40,283	-11%	-$1.13M	0.61%	38
2019 Q1	$8.88M	Hold	364,166	–	–	0.36%	61
2018 Q4	$5.19M	Hold	364,166	–	–	0.22%	83
2018 Q3	$5.54M	Buy	364,166 +108,110	+42%	+$1.66M	0.2%	87
2018 Q2	$4.3M	Buy	256,056 +100,000	+64%	+$1.59M	0.16%	100
2018 Q1	$2.55M	Buy	+156,056	New	+$2.5M	0.1%	126

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Tekla Capital Management's ARRY Position: Q3 2019 in Review

Tekla Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 323,883 shares — an estimated $15M sold.

Tekla Capital Management first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $15M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Tekla Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Tekla Capital Management sold 323,883 Array Biopharma Inc shares in Q3 2019, an estimated $15M.
Tekla Capital Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
Tekla Capital Management's Array Biopharma Inc position peaked at $15M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Tekla Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.